naphazoline has been researched along with Rheumatism in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andreica, I | 1 |
Guminski, B | 1 |
Sokolar, J | 1 |
Patru, A | 1 |
Baraliakos, X | 1 |
Braun, J | 1 |
1 other study available for naphazoline and Rheumatism
Article | Year |
---|---|
[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing].
Topics: COVID-19; Germany; Hospitals; Humans; Naphazoline; Rheumatic Diseases; SARS-CoV-2 | 2021 |